Meeting
2022 ASCO Genitourinary Cancers Symposium
The BARCODE1 study in primary care: Early results targeting men with increased genetic risk of developing prostate cancer—Examining the interim data from a community-based screening program using polygenic risk score to target screening.
Authors
Jana Kathlyn McHugh
Institute of Cancer Research, London, United Kingdom
Jana Kathlyn McHugh , Holly ni Raghallaigh , Elizabeth Bancroft , Zsofia Kote-Jarai , Sarah Benafif , Ros A. Eeles
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Diagnostics and Imaging
Clinical Trial Registration Number
NCT03857477
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 231)
DOI
10.1200/JCO.2022.40.6_suppl.231
Abstract #
231
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
The BARCODE1 pilot study targeting men with increased genetic risk of developing prostate cancer: Examining the feasibility of a community-based screening program using polygenic risk score to target screening.
First Author: Jana Kathlyn McHugh
Poster
2023 ASCO Genitourinary Cancers Symposium
The profile study: Prostate cancer screening in men of Black African and African Caribbean ancestry—Early results.
First Author: Netty Kinsella
Poster
2016 Genitourinary Cancers Symposium
Genetic ancestry and odds of prostate cancer diagnosis in African American and European American men.
First Author: Yaw A. Nyame
Poster
2014 Genitourinary Cancers Symposium
The PROFILE feasibility study: Genetic prostate cancer risk stratification for targeted screening.
First Author: Christos Mikropoulos